$2.32 Billion is the total value of HealthCor Management, L.P.'s 68 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DHR | New | DANAHER CORPORATION | $49,546,000 | – | 150,590 | +100.0% | 2.70% | – |
| ANTM | New | ANTHEM INC | $47,077,000 | – | 101,560 | +100.0% | 2.56% | – |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $35,818,000 | – | 254,230 | +100.0% | 1.95% | – |
| COO | New | COOPER COS INC | $33,570,000 | – | 80,130 | +100.0% | 1.83% | – |
| ABT | New | ABBOTT LABS | $28,529,000 | – | 202,710 | +100.0% | 1.55% | – |
| MDT | New | MEDTRONIC PLCcall | $28,449,000 | – | 275,000 | +100.0% | 1.55% | – |
| HUM | New | HUMANA INC | $25,345,000 | – | 54,640 | +100.0% | 1.38% | – |
| PFE | New | PFIZER INC | $20,024,000 | – | 339,110 | +100.0% | 1.09% | – |
| AVTR | New | AVANTOR INC | $18,052,000 | – | 428,380 | +100.0% | 0.98% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $17,885,000 | – | 28,320 | +100.0% | 0.97% | – |
| ABBV | New | ABBVIE INC | $16,945,000 | – | 125,150 | +100.0% | 0.92% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $14,562,000 | – | 29,000 | +100.0% | 0.79% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $14,076,000 | – | 159,320 | +100.0% | 0.77% | – |
| AMGN | New | AMGEN INC | $14,058,000 | – | 62,490 | +100.0% | 0.76% | – |
| HSIC | New | HENRY SCHEIN INC | $9,894,000 | – | 127,610 | +100.0% | 0.54% | – |
| CCXI | New | CHEMOCENTRYX INC | $8,758,000 | – | 240,530 | +100.0% | 0.48% | – |
| QTRX | New | QUANTERIX CORP | $5,696,000 | – | 134,340 | +100.0% | 0.31% | – |
| SGEN | New | SEAGEN INC | $5,239,000 | – | 33,890 | +100.0% | 0.28% | – |
| New | HYPERFINE INC | $5,014,000 | – | 691,650 | +100.0% | 0.27% | – | |
| STXS | New | STEREOTAXIS INC | $4,071,000 | – | 656,540 | +100.0% | 0.22% | – |
| INSP | New | INSPIRE MED SYS INC | $4,024,000 | – | 17,490 | +100.0% | 0.22% | – |
| AXNX | New | AXONICS INC | $3,300,000 | – | 58,920 | +100.0% | 0.18% | – |
| New | PYXIS ONCOLOGY INC | $2,686,000 | – | 244,838 | +100.0% | 0.15% | – | |
| BBIO | New | BRIDGEBIO PHARMA INCcall | $167,000 | – | 10,000 | +100.0% | 0.01% | – |
| New | EQRX INC*w exp 12/17/202 | $107,000 | – | 99,998 | +100.0% | 0.01% | – | |
| EUCRW | New | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $45,000 | – | 78,059 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.